Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

372.83
Delayed Data
As of Dec 09
 +3.68 / +1.00%
Today’s Change
325.35
Today|||52-Week Range
563.79
-31.32%
Year-to-Date
Cohen's Point72 Bets Big Ahead of Ophthotech Corp. Trial Results
Dec 09 / MotleyFool.com - Paid Partner Content
Play the Trump Factor with these 4 Large-Cap Stocks
Dec 06 / Zacks.com - Paid Partner Content
Stock Market News for December 09, 2016
Dec 09 / Zacks.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Jumped 9.4% in November
Dec 05 / MotleyFool.com - Paid Partner Content
Should Biotech Investors Worry About Donald Trump?
Dec 08 / Zacks.com - Paid Partner Content
5 Top Performing Biotechnology Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
Cramer: With Trump, Everything's a Negotiation
Dec 07 / TheStreet.com - Paid Partner Content
Buy 7 Stocks with Impressive Interest Coverage Ratio
Dec 01 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Booz Allen Hamilton Holding, McDonald's, Regions F...
Dec 07 / Zacks.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close369.15
Today’s open371.13
Day’s range369.77 - 379.50
Volume1,290,897
Average volume (3 months)827,480
Market cap$38.9B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-3.17%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+45.55%
P/E ratio54.4
Price/Sales15.24
Price/Book10.57

Competitors

 Today’s
change
Today’s
% change
SHPGShire+3.02+1.84%
ALXNAlexion Pharmaceutic...+6.07+4.82%
ZTSZoetis Inc+0.21+0.41%
BAXBaxter International...+0.76+1.72%
Data as of 4:01pm ET, 12/09/2016

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$3.13
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs